ArticlePatient preference and adherence2024
An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations.
Lucy Gracen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.